A role for CXCR2 in senescence, but what about in cancer?
1Cell Proliferation Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College, Hammersmith Campus, London, United Kingdom.
Abstract:
Senescence is an irreversible arrest triggered by stresses such as telomere shortening, DNA damage, or oncogenic signaling. Oncogene-induced senescence occurs in preneoplastic lesions, but it is absent from full-blown malignancies suggesting a tumor suppressor function. We recently found that depletion of the receptor CXCR2 [which binds to chemokines such as interleukin (IL)-8 or GROalpha] delays both replicative senescence and impairs the senescence response to oncogenic signals. Our findings suggest that signaling by IL-8 and GROalpha might limit tumor growth by reinforcing senescence early in tumorigenesis. The challenge remains in how to integrate this with the well-known tumor promoting effects of IL-8 and GROalpha.
Insights
Cellular senescence, a tumor suppressor mechanism, is regulated by the receptor CXCR2. Chemokines IL-8 and GROalpha signaling via CXCR2 may limit early tumor growth by promoting senescence.
Area of Science:
- Cellular Biology
- Cancer Research
- Immunology
Background:
- Senescence is a critical cellular process that acts as a tumor suppressor mechanism, preventing uncontrolled cell proliferation.
- Oncogene-induced senescence is observed in early-stage tumors but is often lost in advanced malignancies, indicating a complex role in tumorigenesis.
- The chemokine receptor CXCR2 and its ligands, such as interleukin (IL)-8 and GROalpha, are implicated in both cancer progression and immune responses.
Purpose of the Study:
- To investigate the role of the chemokine receptor CXCR2 in regulating cellular senescence, particularly oncogene-induced senescence.
- To explore how signaling through CXCR2 by chemokines IL-8 and GROalpha influences the senescence response during early tumorigenesis.
Main Methods:
- Experimental depletion of the CXCR2 receptor in cellular models.
- Assessment of replicative senescence and response to oncogenic signals following CXCR2 modulation.
- Analysis of the impact of IL-8 and GROalpha signaling on senescence induction and tumor suppression.
Main Results:
- Depletion of CXCR2 significantly delays the onset of replicative senescence.
- Impairment of CXCR2 signaling hinders the cellular response to oncogenic signals, suggesting a role in preventing oncogene-induced senescence.
- Signaling via IL-8 and GROalpha through CXCR2 appears to reinforce senescence, potentially limiting early tumor development.
Conclusions:
- The CXCR2 receptor plays a crucial role in regulating both replicative and oncogene-induced senescence.
- Signaling by IL-8 and GROalpha mediated by CXCR2 may function as an early tumor suppressor mechanism by promoting senescence.
- Further research is needed to reconcile the pro-senescence effects of CXCR2 signaling with its known pro-tumorigenic roles in later stages of cancer.
More Related Videos
Related Concept Videos
Replicative Cell Senescence
Replicative Cell Senescence
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


